MX2017003166A - Uso de elsiglutida para tratar mucositis gastrointestinal que incluye diarrea inducida por quimioterapia. - Google Patents

Uso de elsiglutida para tratar mucositis gastrointestinal que incluye diarrea inducida por quimioterapia.

Info

Publication number
MX2017003166A
MX2017003166A MX2017003166A MX2017003166A MX2017003166A MX 2017003166 A MX2017003166 A MX 2017003166A MX 2017003166 A MX2017003166 A MX 2017003166A MX 2017003166 A MX2017003166 A MX 2017003166A MX 2017003166 A MX2017003166 A MX 2017003166A
Authority
MX
Mexico
Prior art keywords
elsiglutide
induced diarrhea
gastrointestinal mucositis
including chemotherapy
treat gastrointestinal
Prior art date
Application number
MX2017003166A
Other languages
English (en)
Spanish (es)
Inventor
Boye Knudsen Carsten
Giorgino Ruben
Roncoroni Simona
Calcagnile Selma
Trento Fabio
Spezia Riccardo
Moresino Cecilia
Original Assignee
Helsinn Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsinn Healthcare Sa filed Critical Helsinn Healthcare Sa
Publication of MX2017003166A publication Critical patent/MX2017003166A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2017003166A 2014-09-10 2015-09-02 Uso de elsiglutida para tratar mucositis gastrointestinal que incluye diarrea inducida por quimioterapia. MX2017003166A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462048520P 2014-09-10 2014-09-10
PCT/IB2015/001922 WO2016038455A1 (en) 2014-09-10 2015-09-02 Use of elsiglutide to treat gastrointestinal mucositis including chemotherapy-induced diarrhea

Publications (1)

Publication Number Publication Date
MX2017003166A true MX2017003166A (es) 2017-06-19

Family

ID=54548212

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017003166A MX2017003166A (es) 2014-09-10 2015-09-02 Uso de elsiglutida para tratar mucositis gastrointestinal que incluye diarrea inducida por quimioterapia.

Country Status (18)

Country Link
US (1) US20160067311A1 (enExample)
EP (1) EP3191115A1 (enExample)
JP (1) JP2017532308A (enExample)
KR (1) KR20170052661A (enExample)
CN (1) CN107073081A (enExample)
AR (1) AR103119A1 (enExample)
AU (1) AU2015313919A1 (enExample)
BR (1) BR112017004577A2 (enExample)
CA (1) CA2959110A1 (enExample)
CL (1) CL2017000563A1 (enExample)
EA (1) EA201790552A1 (enExample)
IL (1) IL250928A0 (enExample)
MA (1) MA40623A (enExample)
MX (1) MX2017003166A (enExample)
PH (1) PH12017500426A1 (enExample)
SG (1) SG11201701690WA (enExample)
TW (1) TW201613634A (enExample)
WO (1) WO2016038455A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170087216A1 (en) * 2015-09-17 2017-03-30 Helsinn Healthcare Sa Therapeutic Uses of Elsiglutide
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
IL271245B2 (en) * 2017-06-16 2023-10-01 Zealand Pharma As Dosing regimen for administration of glucagon-like peptide analog (GLP-2) 2
MX2022016367A (es) * 2020-06-19 2023-01-30 Napo Pharmaceuticals Inc Metodos y composiciones para el tratamiento de la diarrea inducida por quimioterapia.
CN115054683B (zh) * 2022-05-19 2023-06-09 唐颢 胰高血糖素样肽-2在制备缓解阿霉素心脏毒性药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200709027B (en) * 2005-04-22 2009-01-28 Novacea Inc Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof
DE602006020123D1 (de) * 2005-05-04 2011-03-31 Zealand Pharma As Glucagon-like-peptide-2- (glp-2-) analoga
EP2314616A1 (en) * 2009-10-23 2011-04-27 Ferring B.V. Peptidic GLP-2 agonists

Also Published As

Publication number Publication date
CA2959110A1 (en) 2016-03-17
MA40623A (fr) 2016-03-17
CL2017000563A1 (es) 2017-09-29
AU2015313919A1 (en) 2017-03-16
AR103119A1 (es) 2017-04-19
KR20170052661A (ko) 2017-05-12
JP2017532308A (ja) 2017-11-02
CN107073081A (zh) 2017-08-18
BR112017004577A2 (pt) 2018-01-23
TW201613634A (en) 2016-04-16
PH12017500426A1 (en) 2017-07-31
EA201790552A1 (ru) 2017-08-31
US20160067311A1 (en) 2016-03-10
SG11201701690WA (en) 2017-04-27
WO2016038455A1 (en) 2016-03-17
IL250928A0 (en) 2017-04-30
EP3191115A1 (en) 2017-07-19

Similar Documents

Publication Publication Date Title
MX2021000077A (es) Composiciones que comprenden cepas bacterianas.
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
MX2018006239A (es) Composiciones que comprenden cepas bacterianas.
MX2018006398A (es) Composiciones que comprenden cepas bacterianas.
MX2018006399A (es) Composiciones que comprenden cepas bacterianas.
MX2017016529A (es) Composiciones que comprenden cepas bacterianas.
MX2017016564A (es) Composiciones que comprenden cepas bacterianas.
MX2017016525A (es) Composiciones que comprenden cepas bacterianas.
MX2017016560A (es) Composiciones que comprenden cepas bacterianas.
MX2020005213A (es) Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos.
MX2017000363A (es) Inhibicion de la via de notch.
SG10201808940WA (en) Nox inhibitor and nfкb inhibitor containing methoxyflavone
PH12016501763B1 (en) Multispecific antibodies
TR201810635T4 (tr) Anti-jagged1 antikorları ve kullanım yöntemleri.
PH12017500426A1 (en) Use of elsiglutide to treat gastrointestinal mucositis including chemotherapy-induced diarrhea
PH12017501864A1 (en) Compositions and methods for treating autism
TR201909125T4 (tr) Yüzey temi̇zlemek i̇çi̇n bi̇r aparat
MX2021005080A (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas.
MX379126B (es) Formulación de factor viii.
PH12018500339A1 (en) Lysobactin for use in the treatment of bovine mastitis
TR201620309A2 (tr) Metformi̇n hi̇droklori̇t ve pi̇ogli̇tazon hi̇droklori̇ti̇n farmasöti̇k bi̇leşi̇mleri̇
UA114708U (uk) Тяговий привід електробуса
AU364097S (en) Transportable accommodation pod called Gunya Pod
IN2014CH00035A (enExample)
UA99992U (ru) 2-оксо-4-фенил-5-циано-1,2,3,4-тетрагидропиридин-6-тиолат n-метилморфолиния